There isn't a day that goes by on Wall Street when certain stocks trading for under $10 a share don't experience massive spikes higher. Traders savvy enough to follow the low-priced names and trade them with discipline and sod risk management are banking ridiculous coin on a regular basis.

Just take a look at some of the big movers to the upside in the under-$10 complex from Wednesday, including Roundy's (RNDY) , which exploded by 63.7%; Amira Nature Foods (ANFI) , which soared by 47%; Pulmatrix (PULM) ,which spiked large by 25.1%; and The9 Limited (NCTY) , which jumped by 18.1%. You don't even have to catch the entire move in lower-priced stocks such as these to make outsized returns when trading.

Low-priced stocks are something that I tweet about on a regular basis. I frequently flag high-probability setups, breakout candidates and low-priced stocks that are acting technically bullish. I like to hunt for low-priced stocks that are showing bullish price and volume trends, since that increases the probability of those stocks heading higher. These setups often produce monster moves higher in very short time frames.

When I trade under-$10 stocks, I do it almost entirely based off of the charts and technical analysis. I also like to find under-$10 stocks with a catalyst, but that's secondary to the chart and volume patterns.

With that in mind, here's a look at several under-$10 stocks that look poised to potentially trade higher from current levels.

Arcadia Biosciences


One under-$10 stock that's starting to move within range of triggering big breakout trade is Arcadia Biosciences  (RKDA - Get Report) , which develops and commercializes agricultural products that enhance the environment and human health. This stock has been slammed lower over the last six months, with shares off huge by 61.2%.

If you take a glance at the chart for Arcadia Biosciences, you'll notice that this stock has been attempting to carve out a major bottoming chart pattern over the last month and change, with shares finding some buying interest multiple times at around $2.70 a share. Shares of Arcadia Biosciences have now started to spike higher and flirt with its 20-day moving average of $2.89 a share. That spike is now quickly pushing this stock within range of triggering a big breakout trade above some key near-term overhead resistance levels.

Market players should now look for long-biased trades in shares of Arcadia Biosciences if it manages to break out above some near-term overhead resistance levels at $3.18 to $3.24 a share and then above more resistance at $3.52 a share with high volume. Look for a sustained move or close above those levels with volume that registers near or above its three-month average action of 27,412 shares. If that breakout triggers soon, then this stock will set up to re-test or possibly take out its next major overhead resistance levels at its 50-day moving average of $3.76 to $4, or even $4.20 to $4.50 a share.

Traders can look to buy this stock off weakness to anticipate that breakout and simply use a stop that sits right around some key near-term support levels at $2.71 to its 52-week low of $2.70 a share. One can also buy shares of Arcadia Biosciences off strength once it starts to clear those breakout levels with volume and then simply use a stop that sits a comfortable percentage from your entry point.

Cancer Genetics

Another under-$10 stock that's quickly moving within range of triggering a big breakout trade is Cancer Genetics  (CGIX - Get Report) , which focuses on developing and commercializing DNA-based tests and services to enhance and personalize the diagnosis, prognosis and treatment of targeted cancers in the U.S., India and China. This stock has been smashed lower by the sellers over the last three months, with shares down huge by 60.4%.

If you take a look at the chart for Cancer Genetics, you'll notice that this stock gapped down sharply lower last week from around $5.50 to under $4 a share with massive downside volume flows. Shares of Cancer Genetics spiked notably higher on Wednesday off its new 52-week low of $3.70 a share with strong upside volume. Volume for the day registered over 360,000 shares, which is well above its three-month average action of 84,879 shares. This high-volume spike is now quickly pushing this stock within range of triggering a big breakout trade above some key near-term overhead resistance.

Market players should now look for long-biased trades in Cancer Genetics if it manages to break out above some key near-term overhead resistance at $4 a share with high volume. Look for a sustained move or close above that level with volume that hits near or above its three-month average action of 84,879 shares. If that breakout gets set off soon, then this stock will set up to re-fill some of its previous gap-down-day zone that started near $5.50 a share.

Traders can look to buy this stock off weakness to anticipate that breakout and simply use a stop that sits right below its new 52-week low of $3.70 a share. One can also buy shares of Cancer Genetics off strength once it starts to take out $4a share with volume and then simply use a stop that sits a comfortable percentage from your entry point.

Aratana Therapeutics


One under-$10 development-stage biopharmaceutical player that's starting to trend within range of triggering a big breakout trade is Aratana Therapeutics  (PETX - Get Report) , which focuses on the licensing, development and commercialization of biopharmaceutical products for the companion animals worldwide. This stock has been under heavy selling pressure over the last three months, with shares off big by 59.4%.

If you take a glance at the chart for Aratana Therapeutics, you'll notice that this stock has been uptrending a bit over the last few weeks, with shares moving higher off its new 52-week low of $5.76 to its recent high of $8.24 a share. During that uptrend, this stock has been making mostly higher lows and higher highs, which is bullish technical price action. Shares of Aratana Therapeutics have now started to spike higher right above some near-term support at $6.50, and it's beginning to trend within range of triggering a big breakout trade above a key downtrend line.

Traders should now look for long-biased trades in Aratana Therapeutics if it manages to break out above a key downtrend line that will trigger over $7.90 to $8.24 a share and then above more key resistance at $8.48 a share with high volume. Look for a sustained move or close above those levels with volume that hits near or above its three-month average action of 512,966 shares. If that breakout develops soon, then this stock will set up to re-test or possibly take out its next major overhead resistance levels at $9.48 to its 50-day moving average of $10.96 a share.

Traders can look to buy this stock off weakness to anticipate that breakout and simply use a stop that sits right around some near-term support at $6.50 a share or just below $6 a share. One can also buy shares of Aratana Therapeutics off strength once it starts to bust above those breakout levels with volume and then simply use a stop that sits a comfortable percentage from your entry point.

Nobilis Health


Another under-$10 health care player that's starting to spike within range of triggering a big breakout trade is Nobilis Health  (HLTH - Get Report) , which together with its subsidiaries, acquires and manages ambulatory surgical centers and health care facilities in the U.S. This stock has been smacked lower by the sellers over the last six months, with shares off large by 52.7%.

If you look at the chart for Nobilis Health, you'll notice that this stock spiked sharply higher on Wednesday right off its 20-day moving average of $3.22 a share with decent upside volume flows. This strong spike to the upside is now quickly pushing shares of Nobilis Health within range of triggering a big breakout trade above a key downtrend line that dates back to early October.

Market players should now look for long-biased trades in Nobilis Health if it manages to break out above a key downtrend line which will trigger over $4 to $4.17 a share and then above its 50-day moving average of $4.28 to more resistance at $4.34 a share with high volume. Look for a sustained move or close above those levels with volume that hits near or above its three-month average action of 675,594 shares. If that breakout develops soon, then this stock will set up to re-test or possibly take out its next major overhead resistance levels at its 200-day moving average of $5.48 to $6 a share, or even $6.50 a share.

Traders can look to buy Nobilis Health off weakness to anticipate that breakout and simply use a stop that sits right around some near-term support levels at $3 to $2.73 share. One can also buy this stock off strength once it starts to trend above those breakout levels with volume and then simply use a stop that sits a comfortable percentage from your entry point.

Himax Technologies


One final under-$10 fabless semiconductor player that's starting to trend within range of triggering a near-term breakout trade is Himax Technologies  (HIMX - Get Report) , which provides display imaging processing technologies to consumer electronics worldwide. This stock has slid lower a bit over the last three months, with shares off by 10.1%.

If you take a glance at the chart for Himax Technologies, you'll notice that this stock spiked sharply higher on Wednesday right above some near-term support at $6 a share with above-average volume. Volume for the day registered over 2.30 million shares, which is just above its three-month average action of 1.80 million shares. That high-volume spike to the upside is now quickly pushing shares of Himax Technologies within range of triggering a near-term breakout trade above some key overhead resistance levels.

Traders should now look for long-biased trades in Himax Technologies if it manages to break out above some near-term overhead resistance levels at its 20-day moving average of $6.29 a share and then above more key resistance at around $6.50 a share with high volume. Look for a sustained move or close above those levels with volume that registers near or above its three-month average action of 1.80 million shares. If that breakout fires off soon, then this stock will set up to re-test or possibly take out its next major overhead resistance levels at its 50-day moving average of $7.02 to $7.40, or even $8 a share.

Traders can look to buy shares of Himax Technologies off weakness to anticipate that breakout and simply use a stop that sits right around some key near-term support levels at $6 to $5.77 a share. One can also buy this stock off strength once it starts to move above those breakout levels with volume and then simply use a stop that sits a comfortable percentage from your entry point.

Disclosure: This article is commentary by an independent contributor. At the time of publication, the author held no positions in the stocks mentioned.